Hua Long
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hua Long has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Baoan Ma
Department of Orthopedic Surgery, Orthopedic Oncology Institute, Tangdu Hospital, Fourth Military Medical University, Xi’an, China
2 shared publications - Zhao Li
Department of Pathology, Johns Hopkins University, Baltimore, MD 21205, USA
2 shared publications - Degang Fan
Department of Orthopedic Surgery, Orthopedics Oncology Institute of Chinese PLA, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi Province, 710038, P. R. China
1 shared publication - Fernando Cardoso Gomes
Department of Rehabilitation, Centro Hospitalar Conde de Sao Januario, Macau
1 shared publication - Hua Yuan
Department of Rehabilitation Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, People’s Republic of China
1 shared publication - Jinhui Zhang
Department of Orthotraumatology, Centro Hospitalar Conde de Sao Januario, Macau
1 shared publication
Latest Publications
- Open Access
- 20 August 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1373
Microwave ablation of malignant extremity bone tumors
The current application of limb salvage process has some unsolved problems, such as prosthesis loosening, which severely limits the function of the preserved limbs. Innovative approaches are needed to further improve functional outcome. Instead of en-bloc resection of tumor-bearing bone, it is dissected from the surrounding normal tissues, followed by devitalizing the bone segment and the extra-cortical bulk by microwave induced hyperthermia in situ through the antenna array. From May 1999 to March 2012, 544 patients with malignant bone tumors of the extremities were treated by the novel method. The over 3-year survival rate was 59.1 % for high-grade malignancy, 88.7 % for low-grade malignancy. In the majority of the patients, cosmetic and useful limbs were preserved. Local recurrence rate was 9.8 % for the high grade malignancy (mainly occurred at the early stage of the research). The overall fracture rate was 2.6 %. Deep infection rate was 1.8 %. The complication rate is lower than the literature reports. After heat necrosis, the dead bone maintains both the osteoconduction and osteoinduction properties. The application of microwave induced hyperthermia for treatment of malignant bone tumors, except the late diagnosed cases who’s tumor-bearing bone was destroyed too severe to do biological reconstruction, is an effective, simple, and inexpensive method. The oncological and functional results are encouraging.
- 20 August 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1373
Open AccessMicrowave ablation of malignant extremity bone tumors
The current application of limb salvage process has some unsolved problems, such as prosthesis loosening, which severely limits the function of the preserved limbs. Innovative approaches are needed to further improve functional outcome. Instead of en-bloc resection of tumor-bearing bone, it is dissected from the surrounding normal tissues, followed by devitalizing the bone segment and the extra-cortical bulk by microwave induced hyperthermia in situ through the antenna array. From May 1999 to March 2012, 544 patients with malignant bone tumors of the extremities were treated by the novel method. The over 3-year survival rate was 59.1 % for high-grade malignancy, 88.7 % for low-grade malignancy. In the majority of the patients, cosmetic and useful limbs were preserved. Local recurrence rate was 9.8 % for the high grade malignancy (mainly occurred at the early stage of the research). The overall fracture rate was 2.6 %. Deep infection rate was 1.8 %. The complication rate is lower than the literature reports. After heat necrosis, the dead bone maintains both the osteoconduction and osteoinduction properties. The application of microwave induced hyperthermia for treatment of malignant bone tumors, except the late diagnosed cases who’s tumor-bearing bone was destroyed too severe to do biological reconstruction, is an effective, simple, and inexpensive method. The oncological and functional results are encouraging.
- 1 September 2013
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 36 (2) , 437-442
Study on osteogenesis promoted by low sound pressure level infrasound in vivo and some underlying mechanisms
- 1 September 2013
- Published by Elsevier in Environmental Toxicology and Pharmacology
- Vol. 36 (2) , 437-442
Study on osteogenesis promoted by low sound pressure level infrasound in vivo and some underlying mechanisms
- Open Access
- 8 December 2010
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1) , 158
Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319
Background: Chordoma was a typically slow-growing tumor. The therapeutic approach to chordoma had traditionally relied mainly on surgical therapy. And the main reason for therapeutic failure was resistance to chemotherapy and radiotherapy. However the refractory mechanism was not clear. The aim of this study was to investigate the expression of three genes (MDR1,HIF-1αandMRP1) associated with resistance to chemotherapy and radiotherapy in chordoma and chordoma cell line CM-319.Materials and methods: Using immunohistochemical techniques, the expression of MDR1, HIF-1α and MRP1 was investigated in 50 chordoma specimen. Using RT-PCR and Western blot, the expression of MDR1, HIF-1α and MRP1 was investigated in chordoma and chordoma cell line CM-319.Results: Expression of MDR1, HIF-1α and MRP1 was observed in 10%, 80% and 74% of all cases, respectively. Expression of MRP1 was correlated with HIF-1α. On the other hand, expression of MDR1 was not correlated with the expression of HIF-1α or MRP1. The expression of HIF-1α and MRP1 was observed, but MDR1 was not observed in chordoma and CM-319.Conclusion: Expression of HIF-1α and MRP1 was observed in most chordoma specimen and CM-319 cell line; expression of HIF-1α correlated with MRP1. HIF-1α and MRP1 may play a role in the multidrug resistance of chordoma to chemotherapy.
- 8 December 2010
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 29 (1) , 158
Open AccessExpression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319
Background: Chordoma was a typically slow-growing tumor. The therapeutic approach to chordoma had traditionally relied mainly on surgical therapy. And the main reason for therapeutic failure was resistance to chemotherapy and radiotherapy. However the refractory mechanism was not clear. The aim of this study was to investigate the expression of three genes (MDR1,HIF-1αandMRP1) associated with resistance to chemotherapy and radiotherapy in chordoma and chordoma cell line CM-319.Materials and methods: Using immunohistochemical techniques, the expression of MDR1, HIF-1α and MRP1 was investigated in 50 chordoma specimen. Using RT-PCR and Western blot, the expression of MDR1, HIF-1α and MRP1 was investigated in chordoma and chordoma cell line CM-319.Results: Expression of MDR1, HIF-1α and MRP1 was observed in 10%, 80% and 74% of all cases, respectively. Expression of MRP1 was correlated with HIF-1α. On the other hand, expression of MDR1 was not correlated with the expression of HIF-1α or MRP1. The expression of HIF-1α and MRP1 was observed, but MDR1 was not observed in chordoma and CM-319.Conclusion: Expression of HIF-1α and MRP1 was observed in most chordoma specimen and CM-319 cell line; expression of HIF-1α correlated with MRP1. HIF-1α and MRP1 may play a role in the multidrug resistance of chordoma to chemotherapy.